These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17408235)

  • 1. Vectors for airway gene delivery.
    Davis PB; Cooper MJ
    AAPS J; 2007 Jan; 9(1):E11-7. PubMed ID: 17408235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid.
    Chen X; Shank S; Davis PB; Ziady AG
    Mol Ther; 2011 Jan; 19(1):93-102. PubMed ID: 20959809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonviral gene therapy.
    Li S; Ma Z
    Curr Gene Ther; 2001 Jul; 1(2):201-26. PubMed ID: 12108955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanoparticles for gene delivery.
    Zhao Y; Huang L
    Adv Genet; 2014; 88():13-36. PubMed ID: 25409602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in cystic fibrosis gene therapy.
    Griesenbach U; Geddes DM; Alton EW
    Curr Opin Pulm Med; 2004 Nov; 10(6):542-6. PubMed ID: 15510064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells.
    Zou S; Scarfo K; Nantz MH; Hecker JG
    Int J Pharm; 2010 Apr; 389(1-2):232-43. PubMed ID: 20080162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
    Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
    Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the nuclear pore dilating agent trans-cyclohexane-1,2-diol in differentiated airway epithelium.
    Griesenbach U; Wilson KM; Farley R; Meng C; Munkonge FM; Cheng SH; Scheule RK; Alton EW
    J Gene Med; 2012 Jul; 14(7):491-500. PubMed ID: 22711445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.
    Takahashi Y; Nishikawa M; Takakura Y
    Front Biosci (Schol Ed); 2012 Jan; 4(1):133-41. PubMed ID: 22202048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo.
    Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH
    Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-based nanoparticles as nonviral gene delivery vectors.
    Pezzoli D; Kajaste-Rudnitski A; Chiesa R; Candiani G
    Methods Mol Biol; 2013; 1025():269-79. PubMed ID: 23918345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle-mediated gene delivery.
    Jin S; Leach JC; Ye K
    Methods Mol Biol; 2009; 544():547-57. PubMed ID: 19488722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of bacterial killing activity of human respiratory cystic fibrosis cells through cationic vector-mediated cystic fibrosis transmembrane conductance regulator gene transfer.
    Biffi A; Sersale G; Cassetti A; Villa A; Bordignon C; Assael BM; Conese M
    Hum Gene Ther; 1999 Aug; 10(12):1923-30. PubMed ID: 10466626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
    McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; Gordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Scheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Porteous DJ; Gill DR; Collie DD
    Gene Ther; 2011 Oct; 18(10):996-1005. PubMed ID: 21512505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonviral gene delivery: what we know and what is next.
    Gao X; Kim KS; Liu D
    AAPS J; 2007 Mar; 9(1):E92-104. PubMed ID: 17408239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy.
    Maitra A
    Expert Rev Mol Diagn; 2005 Nov; 5(6):893-905. PubMed ID: 16255631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineering liposomal nanoparticles for targeted gene therapy.
    Zylberberg C; Gaskill K; Pasley S; Matosevic S
    Gene Ther; 2017 Aug; 24(8):441-452. PubMed ID: 28504657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface nucleolin serves as receptor for DNA nanoparticles composed of pegylated polylysine and DNA.
    Chen X; Kube DM; Cooper MJ; Davis PB
    Mol Ther; 2008 Feb; 16(2):333-42. PubMed ID: 18059369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells.
    Colin M; Harbottle RP; Knight A; Kornprobst M; Cooper RG; Miller AD; Trugnan G; Capeau J; Coutelle C; Brahimi-Horn MC
    Gene Ther; 1998 Nov; 5(11):1488-98. PubMed ID: 9930302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia.
    Fasbender A; Zabner J; Zeiher BG; Welsh MJ
    Gene Ther; 1997 Nov; 4(11):1173-80. PubMed ID: 9425440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.